Analysis of data from the 2006-2008 National Survey of Family Growth reveals that use of emergency contraception in the US has more than doubled since 2002, from 4.2% to 9.7%, but remains highly dependent on whether physicians provide counseling about EC.
Although mode of delivery does not seem to influence the occurrence of postpartum depression, a number of other factors do, according to a study.
A diet high in sodium and low in potassium raises the risk of death from any cause by 50% and doubles the risk of death from heart attack, according to a new study.
A Virginia woman went to her gynecologist for an annual physical. The pap smear revealed human papillomavirus and abnormal cells. A cone biopsy was performed and the pathology report from the biopsy revealed adenoid cystic carcinoma. However, the gynecologist did not tell the patient about the cervical cancer; instead she was told to undergo a hysterectomy.
Women who don't smoke, have a body mass index lower than 25, exercise at least 30 minutes a day, and adhere to a Mediterranean-style diet, have a significantly lower risk of sudden cardiac death, a new study finds.
Over a 3-year period, exemestane reduced the relative incidence of invasive breast cancer by 65% in healthy postmenopausal women at moderately increased risk for breast cancer, according to the findings of a randomized trial.
Researchers in England have found a strong link between the number of eggs retrieved in a single cycle of in vitro fertilization and live birth rate.
Researchers have identified a gene associated with 70% of estrogen-receptor-negative breast cancers, according to a new study.
More information is needed before physicians should start routinely screening pregnant women for vitamin D deficiency, according to an ACOG recently issued committee opinion statement.
Simultaneous screening with serum cancer antigen (CA)-125 and transvaginal ultrasound does not reduce the number of deaths from ovarian cancer, according to trial findings.
Use of long-acting reversible contraception - intrauterine devices and subdermal implants - in the United States more than doubled between 2002 and 2008, according to a new study.
Those who had hoped that the combination of routine screening with cancer antigen 125 (CA-125) and pelvic ultrasound would promote an earlier diagnosis and improved survival for women with ovarian cancer were dealt a harsh blow when the PLCO trail results were reported.
Ectopic pregnancy is one of the most challenging medical conditions.
This depends on the types and the severity of the prolapse. Generally, most women are not aware of the presence of mild prolapse. When prolapse is moderate or severe, symptoms may include sensation of a lump inside the vagina or disturbance in the function of the affected organs, such as: Bladder: stress incontinence, urgency, frequency, incomplete emptying, dribbling, recurrent urine infections.
Symptoms related to menopause, including insomnia, nervousness, melancholia, vertigo, weakness, fatigue, hot flashes, vaginal dryness, and urinary incontinence, denote a decline in a woman's quality of life. Further, the symptoms a woman may experience vary according to age.
With a number of clinical studies now completed, the launch of drospirenone/ethinyl estradiol (Yasmin®) in the United States and Europe is expected in the near future. An international panel of physicians involved with the development of drospirenone/ethinyl estradiol recently described the potential benefits of the new oral contraceptive (OC) to clinicians attending an industry-sponsored symposium held during the XVI FIGO World Congress of Gynecology and Obstetrics.
There has been an explosion of hormone replacement therapy research over the past few years. The task of wading through the data to determine what is best for a particular patient, however, can be daunting at best and confusing at worst, said Dr. Karen Carlson, Massachusetts General Hospital, Boston, to delegates at the Pri-Med East in Boston.
The topic of hormone replacement therapy (HRT) continues to emerge as a central theme that we, as clinicians to female patients, address every day. We recognize that the public is much more aware of and interested in HRT now than was the case a decade ago.
Isoflavones are gaining popularity as alternatives to hormone replacement therapy. However, few guidelines exist to inform the public as to an appropriate dose.
Osteoporosis is the gradual declining in bone mass with age, leading to increased bone fragility and fractures. Fractures in hip and spine are known to be the most important complication of the disease which leads in the annual mortality rate of 20% and serious morbidity rate of 50%.
To evaluate the impact of osteoporosis on the patients' quality of life, particularly in the absence of fractures.
Breast cancer is a growing concern among premenopausal women. With an emphasis on this patient population, this article discusses the known risk factors for breast cancer; models for quantitative risk assessment; and strategies for modifying breast cancer risk, including screening mammography, prophylactic mastectomy, and primary pharmacologic prevention.
Postmenopausal osteoporosis is a major health problem, primarily because of the severe morbidity and mortality associated with osteoporotic fractures.
The age at which a woman reaches menopause is 85% genetically determined, according to new research published Thursday, in Europe's leading reproductive medicine journal, Human Reproduction*.
A report just published in the Journal of the American Medical Association confirmed previous studies which found that women who take hormone replacement therapy (HRT) may develop denser breast tissue, which in turn may make it more difficult to detect breast cancer through mammography.
Both the estrogen receptor (ER) and vitamin D receptor (VDR) belong to the same superfamily of nuclear receptors and both receptors are activated by interaction with their ligands.
Like the proverbial elephant, osteoporosis has been described in ways that vary according to the scientific orientation of the describer. It has been defined clinically as the presence of fracture; biomechanically as decreased bone strength; radiographically as osteopenia; histomorphometrically as reduced bone matrix per unit of bone volume; and epidemiologically as increased fracture risk.
There are many ways to take estrogens and many philosophies of management. The views expressed on this page represent the opinion of the author and may or may not conform to the current "standard of care" prevalent in the United States today.
A 27-year study of 1300 women undergoing retropubic cystourethropexy using either the modified Marshall-Marchetti-Krantz procedure or the modified Pereyra procedure compares long-term results when the type of surgery is selected on the basis of patient criteria.
Natural Estrogens, Selective Estrogens, Fantasy Estrogens... What is the Perfect Estrogen?